Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Igm Biosciences Inc (IGMS)

Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Igm Biosciences Inc 325 EAST MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 USA

igmbio.com P: 650-965-7873

Description:

IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences Inc. is based in Mountain View, California.

Key Statistics

Overview:

Market Capitalization, $K 566,119
Enterprise Value, $K 453,009
Shares Outstanding, K 58,787
Annual Sales, $ 2,130 K
Annual Net Income, $ -246,420 K
Last Quarter Sales, $ 650 K
Last Quarter Net Income, $ -60,700 K
EBIT, $ -263,460 K
EBITDA, $ -264,320 K
60-Month Beta 0.26
% of Insider Shareholders 56.91%
% of Institutional Shareholders 42.79%
Float, K 25,331
% Float 43.09%
Short Volume Ratio 0.51

Growth:

1-Year Return -18.63%
3-Year Return -85.62%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.01 on 03/07/24
Latest Earnings Date 05/10/24
Earnings Per Share ttm -4.81
EPS Growth vs. Prev Qtr 2.88%
EPS Growth vs. Prev Year 15.13%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IGMS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -103.20%
Return-on-Assets % -53.53%
Profit Margin % -11,569.01%
Debt/Equity 0.00
Price/Sales 267.72
Price/Cash Flow N/A
Price/Book 2.71
Book Value/Share 3.46
Interest Coverage -3.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar